Literature DB >> 15957517

Validation of the NARCOMS Registry: pain assessment.

Ruth Ann Marrie1, Gary Cutter, Tuula Tyry, Olympia Hadjimichael, Timothy Vollmer.   

Abstract

The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is a multiple sclerosis (MS) self-report registry with more than 24,000 participants. Participants report disability status upon enrollment, and semi-annually using Performance Scales (PS), Patient Determined Disease Steps (PDDS) and a pain question. In November 2000 and 2001, we also collected the Pain Effects Scale (PES). Our aim was to validate the NARCOMS pain question using the PES as our criterion measure. We measured correlations between the pain question and age, disease duration, various PS subscales and PDDS to assess construct validity. We correlated pain question responses in participants who reported no change in PDSS or the PS subscales between questionnaires to determine test-retest reliability. We measured responsiveness in participants who reported a substantial change in the sensory, spasticity PS subscales. The correlation between the pain question and PES was r = 0.61 in November 2000, and r = 0.64 in November 2001 (both P < 0.0001). Correlations between the pain question and age, and disease duration were low, indicating divergent validity. Correlations between the pain question and spasticity, sensory PS subscales and PDSS were moderate, indicating convergent validity. Test-retest reliability was r = 0.84 (P < 0.0001). Responsiveness was 70.7%. The pain question is a valid self-report measure of pain in MS.

Entities:  

Mesh:

Year:  2005        PMID: 15957517     DOI: 10.1191/1352458505ms1167oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

Review 1.  Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.

Authors:  Cindy J Nowinski; Deborah M Miller; David Cella
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Depression and Age at First Neurology Appointment Associated with Receipt of Behavioral Medicine Services Within 1 Year in a Multiple Sclerosis Population.

Authors:  Benjamin Greenberg; Youran Fan; Lucille Carriere; Amy Sullivan
Journal:  Int J MS Care       Date:  2017 Jul-Aug

3.  Smokers with MS have greater decrements in quality of life and disability than non-smokers.

Authors:  Farren Bs Briggs; Douglas D Gunzler; Daniel Ontaneda; Ruth Ann Marrie
Journal:  Mult Scler       Date:  2017-01-06       Impact factor: 6.312

4.  Pseudobulbar affect: Prevalence and association with symptoms in multiple sclerosis.

Authors:  Kathryn C Fitzgerald; Amber Salter; Tuula Tyry; Robert J Fox; Gary Cutter; Ruth Ann Marrie
Journal:  Neurol Clin Pract       Date:  2018-12

5.  The multiple sclerosis rating scale, revised (MSRS-R): development, refinement, and psychometric validation using an online community.

Authors:  Paul Wicks; Timothy E Vaughan; Michael P Massagli
Journal:  Health Qual Life Outcomes       Date:  2012-06-18       Impact factor: 3.186

6.  Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ).

Authors:  Paul Wicks; Michael Massagli; Amit Kulkarni; Homa Dastani
Journal:  J Med Internet Res       Date:  2011-01-24       Impact factor: 5.428

7.  Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.

Authors:  Eric Chamot; Ilya Kister; Gary R Cutter
Journal:  BMC Neurol       Date:  2014-10-03       Impact factor: 2.474

8.  Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey.

Authors:  John R Rinker; Amber R Salter; Harrison Walker; Amy Amara; William Meador; Gary R Cutter
Journal:  BMJ Open       Date:  2015-01-08       Impact factor: 2.692

9.  Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.

Authors:  Riley Bove; Charles C White; Gavin Giovannoni; Bonnie Glanz; Victor Golubchikov; Johnny Hujol; Charles Jennings; Dawn Langdon; Michelle Lee; Anna Legedza; James Paskavitz; Sashank Prasad; John Richert; Allison Robbins; Susan Roberts; Howard Weiner; Ravi Ramachandran; Martyn Botfield; Philip L De Jager
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-10-15

10.  Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.

Authors:  Olympia Hadjimichael; Timothy Vollmer; MerriKay Oleen-Burkey
Journal:  Health Qual Life Outcomes       Date:  2008-11-14       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.